Knott, Gavin J. http://orcid.org/0000-0002-9007-6273
Thornton, Brittney W.
Lobba, Marco J.
Liu, Jun-Jie
Al-Shayeb, Basem
Watters, Kyle E. http://orcid.org/0000-0001-6858-6632
Doudna, Jennifer A. http://orcid.org/0000-0001-9161-999X
Article History
Received: 9 November 2018
Accepted: 27 February 2019
First Online: 1 April 2019
Competing interests
: The Regents of the University of California have patents pending for CRISPR technologies on which the authors are inventors. J.A.D. is a co-founder of Caribou Biosciences, Editas Medicine, Intellia Therapeutics, Scribe Therapeutics and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Caribou Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Synthego, Mammoth Biosciences and Inari. J.A.D. is a Director at Johnson & Johnson and has sponsored research projects by Pfizer and Biogen.